Exercise Pill: New Drug Mimics Workouts and Curbs Appetite
Experimental biotech pill ENV-308 delivers an encouraging safety profile in a Phase 1 clinical trial of 88 healthy adults, according to startup biotech company Enveda. Designed to curb appetite by mimicking the body’s natural response to vigorous exercise, the daily oral tablet replicates a molecule discovered by Stanford scientists in 2022 without triggering the gastrointestinal … Read more